Figures & data
Figure 1. PRISMA flow diagram of screened and the selection process of studies on pooled prevalence of HPV vaccine uptake and determinant factors among adolescent school girls in sub-Saharan Africa, 2023.
![Figure 1. PRISMA flow diagram of screened and the selection process of studies on pooled prevalence of HPV vaccine uptake and determinant factors among adolescent school girls in sub-Saharan Africa, 2023.](/cms/asset/64b60ca0-e08c-4553-a26f-dc23fa2dbfe7/khvi_a_2326295_f0001_oc.jpg)
Table 1. Included study characteristics to estimate the pooled prevalence of HPV vaccine uptake and determinant factors in sub-Saharan Africa, 2023.
Figure 2. Forest plot depicting the pooled prevalence of HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.
![Figure 2. Forest plot depicting the pooled prevalence of HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.](/cms/asset/a1ef6f3b-8400-4853-b895-169c68a63624/khvi_a_2326295_f0002_oc.jpg)
Figure 3. The pooled odd ratio of the association between good knowledge about HPV vaccine and HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.
![Figure 3. The pooled odd ratio of the association between good knowledge about HPV vaccine and HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.](/cms/asset/6948f9d1-9146-492d-8f1d-3677973c245d/khvi_a_2326295_f0003_oc.jpg)
Figure 4. The pooled odd ratio of the association between positive attitude about HPV vaccine and HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.
![Figure 4. The pooled odd ratio of the association between positive attitude about HPV vaccine and HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.](/cms/asset/73d7c34a-cb01-463e-ae44-96f63c3587a0/khvi_a_2326295_f0004_oc.jpg)
Figure 5. Forest plot depicting sub-group analysis by country for the pooled prevalence of HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.
![Figure 5. Forest plot depicting sub-group analysis by country for the pooled prevalence of HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.](/cms/asset/7908a8f1-4eb5-464c-9956-ccae9fa200c7/khvi_a_2326295_f0005_oc.jpg)
Table 2. Meta-regression to identify the source of heterogeneity for the estimated pooled prevalence of human papilloma vaccine uptake and determinant factors among adolescent school girls in sub-Saharan Africa, 2023.
Figure 6. Funnel plot depicting publication bias of studies reporting on the pooled prevalence of HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.
![Figure 6. Funnel plot depicting publication bias of studies reporting on the pooled prevalence of HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.](/cms/asset/b371f6fe-f055-4dd3-849e-ae566b566fb1/khvi_a_2326295_f0006_oc.jpg)
Figure 7. Sensitivity analysis on the studies included in the pooled prevalence of HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.
![Figure 7. Sensitivity analysis on the studies included in the pooled prevalence of HPV vaccine uptake among adolescent school girls in sub-Saharan Africa, 2023.](/cms/asset/74515886-6ca6-4cb6-8680-d72d323d9f8d/khvi_a_2326295_f0007_oc.jpg)
Supplementary Material1 PRISMA 2020 Checklist.doc
Download MS Word (258.6 KB)Supplementary Material 2 Search strategy.docx
Download MS Word (16.5 KB)Supplementary Material 3 Newcastle Ottowa Scale.docx
Download MS Word (20.9 KB)Data availability statement
All associated data and supporting information are included in this systematic review and meta-analysis.